RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Benefits of Inducing ApoA1 Synthesis Still Unclear: Results from ASSERT
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 14
OP 15
DO 10.1177/155989771010006
UL http://mdc.sagepub.com/content/10/10/14.abstract
AB This article discusses data from the ASSERT trial that was designed to test whether treatment with RVX-208, an oral drug that induces apolipoprotein A1 (apoA1) synthesis, would lead to increased apoA1 levels.